In non-Hodgkin lymphoma (NHL), PRMT5 modulates the TP53/NF-κB p52/BCL3 pathway, which enhances Cyclin D1 proliferative signaling. The gene discussed is NFKB1; the disease is non-Hodgkin lymphoma.